interCurve Competitors

Fractal is a publicly listed global enterprise AI company with a vision to power every human decision in the enterprise. With a workforce of over 5,000 professionals across North America, EMEA, and Asia-Pacific, Fractal partners with Fortune 500® companies to embed AI into critical business decisions across growth, supply chains, pricing, and customer experience. Committed to sustained innovation, Fractal invests more than 5% of its annual revenue in AI research and development, supporting foundational AI research, product development, and IP creation that address both immediate client needs and long-term technological advancement. For more information, visithttps://fractal.ai/?utm_source=linkedin&utm_medium=coverpic&utm_campaign=socialmedia

Quantum Health is the industry’s leading healthcare navigation company that helps organizations lower healthcare costs by simplifying care journeys and improving outcomes. Serving more than 500 clients and 20+ million members, Quantum Health provides a single point of contact across the entire healthcare journey, combining compassionate support and clinical expertise with advanced technology and predictive AI built on 25+ years of proprietary data. Through the acquisition and integration of Embold Health’s provider analytics and CirrusMD’s virtual care platform, Quantum Health delivers the industry’s most complete suite of solutions. Members gain immediate on-demand access to physician-led virtual care and patented provider-quality data that guides them to the highest-performing specialists. Only Quantum Health engages directly with providers to take immediate action at a member’s first moment of need, delivering better outcomes, a superior member experience and more efficient healthcare spending.

Lunit is a leading provider of AI solutions for cancer diagnostics and therapeutics, with a mission to conquer cancer through AI. Our clinically proven AI enables healthcare providers to detect cancer earlier, make more precise treatment decisions, and improve patient outcomes — transforming how cancer is diagnosed and treated. Our technology spans the entire cancer continuum, from risk prediction and screening optimization to early detection and precision oncology. Lunit’s breast and chest imaging AI boosts diagnostic accuracy and efficiency, while our pathology AI is leveraged by leading pharmaceutical companies to drive biomarker discovery and companion diagnostics (CDx) development. Trusted by 10,000+ sites across 65+ countries, Lunit continues to redefine global standards in data-driven cancer care. Learn more about our technology and mission at www.lunit.io/en